Related Experiment Video
Updated: Apr 27, 2026

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
Published on: November 11, 2025
Relationship of p53 accumulation in peripheral tissues of high-fat diet-induced obese rats with decrease in metabolic
Reza Homayounfar1, Mahmood Jeddi-Tehrani2, Makan Cheraghpour3
1Department of Biochemistry, Fasa University of Medical Sciences, Fasa, Iran.
Abstract:
This paper aimed to explore the role of p53 in adipose and some other peripheral tissues of a diet-induced obese model and targeted it using pharmacological approach to ameliorate diet-induced insulin resistance. Five week old male Wistar rats were randomly divided into three groups and fed on low-fat diet (13% control lean group), high-fat diet (41% obese group), or high-fat diet plus a single dose of pifithrin-α in the end of experiments (PFT group). Insulin, glucose, and other serum parameters were analyzed by standard colorimetric kits. Protein levels were evaluated by immunoblotting and immunofluorescence methods. After 12weeks, both body weight and insulin resistance were significantly higher in obese rats than in the control ones. P53 and PTEN protein levels were markedly elevated in peripheral tissues in addition to adipose tissues. AKT activation was decreased in the peripheral tissues of obese rats and was in correlation with the increase of p53 and PTEN level. Systemic pifithrin-α administration considerably diminished p53 levels and ameliorated AKT phosphorylation in all peripheral tissues including adipose tissues. Interestingly, the systemic inhibition of p53 was in correlation with improving insulin glucose at serum level. The present results clearly showed that p53 activation in peripheral tissues was in correlation with decreased insulin action. These results indicated p53 activation in the peripheral tissues of obese subjects as a protective mechanism against chronic insulin elevation, suggested that p53 could be a new target for the treatment of type 2 diabetes.
Insights
Diet-induced obesity increases p53 and PTEN proteins in peripheral tissues, impairing insulin action. Pharmacological inhibition of p53 (pifithrin-α) improved insulin sensitivity, suggesting p53 as a potential therapeutic target for type 2 diabetes.
Area of Science:
- Metabolic research
- Molecular biology
- Endocrinology
Background:
- Diet-induced obesity is linked to insulin resistance.
- The role of p53 in peripheral tissues during obesity is not fully understood.
Purpose of the Study:
- To investigate the role of p53 in adipose and peripheral tissues in diet-induced obesity.
- To evaluate the therapeutic potential of targeting p53 to ameliorate insulin resistance.
Main Methods:
- Wistar rats were fed low-fat or high-fat diets for 12 weeks.
- Some rats received pifithrin-α (PFT), a p53 inhibitor.
- Serum parameters (insulin, glucose) and protein levels (p53, PTEN, AKT) were analyzed.
Main Results:
- Obese rats showed increased body weight, insulin resistance, and elevated p53 and PTEN levels in peripheral tissues.
- AKT activation was decreased in obese rats, correlating with higher p53 and PTEN.
- Pifithrin-α treatment reduced p53 levels, enhanced AKT phosphorylation, and improved insulin sensitivity.
Conclusions:
- p53 activation in peripheral tissues is associated with decreased insulin action in diet-induced obesity.
- Targeting p53 pharmacologically offers a potential therapeutic strategy for type 2 diabetes.
- p53 may act as a protective mechanism against chronic insulin elevation in obese individuals.
Related Concept Videos
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Obesity

